These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20530040)

  • 1. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
    Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D
    Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia.
    Seligman R; Seligman BG; Teixeira PJ
    J Bras Pneumol; 2011; 37(4):495-503. PubMed ID: 21881740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
    J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
    Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
    Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.
    Krüger S; Papassotiriou J; Marre R; Richter K; Schumann C; von Baum H; Morgenthaler NG; Suttorp N; Welte T;
    Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin in early onset ventilator-associated pneumonia.
    Zielińska-Borkowska U; Skirecki T; Złotorowicz M; Czarnocka B
    J Hosp Infect; 2012 Jun; 81(2):92-7. PubMed ID: 22552164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.
    Hillas G; Vassilakopoulos T; Plantza P; Rasidakis A; Bakakos P
    Eur Respir J; 2010 Apr; 35(4):805-11. PubMed ID: 19717486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
    Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.
    Birdir C; Janssen K; Stanescu AD; Enekwe A; Kasimir-Bauer S; Gellhaus A; Kimmig R; Köninger A
    Arch Gynecol Obstet; 2015 Nov; 292(5):1033-42. PubMed ID: 25975456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.
    Hoeboer SH; Alberts E; van den Hul I; Tacx AN; Debets-Ossenkopp YJ; Groeneveld AB
    J Infect; 2012 May; 64(5):484-93. PubMed ID: 22248983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High levels of atrial natriuretic peptide and copeptin and mortality risk].
    Rey C; García-Cendón C; Martínez-Camblor P; López-Herce J; Concha-Torre A; Medina A; Vivanco-Allende A; Mayordomo-Colunga J
    An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
    Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM
    Crit Care; 2011; 15(2):R88. PubMed ID: 21385367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of combined procalcitonin and lipopolysaccharide-binding protein as prognostic markers of mortality in patients with ventilator-associated pneumonia.
    Rumende CM; Mahdi D
    Acta Med Indones; 2013 Apr; 45(2):89-93. PubMed ID: 23770787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.